Azithromycin mitigates human rhinovirus impact on barrier integrity and function in non-diseased airway epithelium
Azithromycin improves symptomology in various chronic airway diseases exacerbated by viral infections. However, the mechanisms underlying the apparent antiviral effects of azithromycin remain unclear.
Keywords:
Airway epithelium; azithromycin; barrier function; human rhinovirus; tight junction
Abstract:
Azithromycin improves symptomology in various chronic airway diseases exacerbated by viral infections. However, the mechanisms underlying the apparent antiviral effects of azithromycin remain unclear.